Skip to content
Screener

Cardiol Therapeutics CRDL Q1 2026 earnings

Reported May 11, 2026 · After market close

EPS-$0.07In line
EPS estimate-$0.07

Next report

Date not yet announced

FAQ

When did Cardiol Therapeutics report Q1 2026 earnings?
Cardiol Therapeutics (CRDL) reported Q1 2026 earnings on May 11, 2026 after market close.
What were Cardiol Therapeutics's Q1 2026 revenue and EPS?
Cardiol Therapeutics reported eps of $-0.07 for Q1 2026.
Did Cardiol Therapeutics beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.07 by $0.00.
How did Cardiol Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 30.0% from $-0.10.